linaclotide

본문 바로가기


Home > Product > linaclotide
Selling leads
linaclotide
Posting date : Jun 23, 2026
Membership
Free Member Scince Jun 22, 2026
FOB Price
1
Min. Order Quantity
10g
Supply Abillity
50000kgs
Port
Beijing
Payment Terms
100% TT in Advance
Package
1
Keyword :
API
Category
Contact
Winnie Wang
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
JINLAN Brand
Model Number
851199-59-2
HS-CODE
-
Package & Delivery Lead Time
Package
1
Delivery Lead Time
7-14
Detailed Description
Linaclotide (also known as Linaclotide Acetate, brand name Linzess) is a synthetic 14-amino-acid cyclic peptide with CAS No. 851199-59-2 and EINECS number 251-228-4. It carries molecular formula C₅₉H₇₉N₁₅O₂₁S₆ and molecular weight of 1526.74, classified as an FDA-approved GC-C (guanylate cyclase-C) agonist that acts locally in the intestinal tract. Clinically, it is indicated for adult patients with irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC), widely used in gastrointestinal pharmacology research, peptide drug development and formulation consistency evaluation.
This product appears as a white solid powder with a melting point of 231–235 °C (decomposed), predicted boiling point 2045.0±65.0 °C and density of 1.60. It is hygroscopic and soluble in DMSO, methanol and water with mild heating required for full dissolution. For long-term stable storage, it needs to be kept refrigerated under inert atmosphere. Supplied as high-purity research-grade peptide raw material complying with USP/EP/BP standards, it serves as a core reference compound for intestinal motility mechanism studies, peptide synthesis process development and preclinical gastrointestinal drug screening.

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top